Executive VP and GM Global Reference Laboratories Michael Lane Sold A Bunch Of Shares In IDEXX Laboratories

We wouldn't blame IDEXX Laboratories, Inc. (NASDAQ:IDXX) shareholders if they were a little worried about the fact that Michael Lane, the Executive VP and GM Global Reference Laboratories recently netted about US$2.7m selling shares at an average price of US$689. That sale reduced their total holding by 48% which is hardly insignificant, but far from the worst we've seen.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

IDEXX Laboratories Insider Transactions Over The Last Year

Notably, that recent sale by Michael Lane is the biggest insider sale of IDEXX Laboratories shares that we've seen in the last year. So what is clear is that an insider saw fit to sell at around the current price of US$676. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).

Insiders in IDEXX Laboratories didn't buy any shares in the last year. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

Check out our latest analysis for IDEXX Laboratories

If you are like me, then you will not want to miss this free list of small cap stocks that are not only being bought by insiders but also have attractive valuations.

Does IDEXX Laboratories Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. IDEXX Laboratories insiders own 0.3% of the company, currently worth about US$136m based on the recent share price. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

So What Does This Data Suggest About IDEXX Laboratories Insiders?

Insiders sold stock recently, but they haven't been buying. Looking to the last twelve months, our data doesn't show any insider buying. But since IDEXX Laboratories is profitable and growing, we're not too worried by this. It is good to see high insider ownership, but the insider selling leaves us cautious. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing IDEXX Laboratories. At Simply Wall St, we found 1 warning sign for IDEXX Laboratories that deserve your attention before buying any shares.

Of course IDEXX Laboratories may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.